42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acoustofluidic separation of cells and particles

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acoustofluidics, the integration of acoustics and microfluidics, is a rapidly growing research field that is addressing challenges in biology, medicine, chemistry, engineering, and physics. In particular, acoustofluidic separation of biological targets from complex fluids has proven to be a powerful tool due to the label-free, biocompatible, and contact-free nature of the technology. By carefully designing and tuning the applied acoustic field, cells and other bioparticles can be isolated with high yield, purity, and biocompatibility. Recent advances in acoustofluidics, such as the development of automated, point-of-care devices for isolating sub-micron bioparticles, address many of the limitations of conventional separation tools. More importantly, advances in the research lab are quickly being adopted to solve clinical problems. In this review article, we discuss working principles of acoustofluidic separation, compare different approaches of acoustofluidic separation, and provide a synopsis of how it is being applied in both traditional applications, such as blood component separation, cell washing, and fluorescence activated cell sorting, as well as emerging applications, including circulating tumor cell and exosome isolation.

          Acoustofluidics: From lab to clinic

          Research into using sound waves to separate biological particles from fluid moving through tiny channels is rapidly advancing, but more is needed to develop real-life clinical applications. Tony Jun Huang of Duke University in the US and colleagues reviewed the latest studies in the rapidly growing field of ‘acoustofluidic separation’. While progress has been made in using the technology to separate micro-sized objects like cells and bacteria from fluids, few breakthroughs have been achieved for separating nanoparticles, like lipids and viruses. Also, advances are needed to speed up the separation process. Still, the field shows much promise for the development of label-free, point-of-care devices for cancer diagnosis, placental health monitoring, and isolating bacteria from water or food. Focusing on product development and technological improvements will enable this technology to find real-world applications, the researchers conclude.

          Related collections

          Most cited references121

          • Record: found
          • Abstract: found
          • Article: not found

          Droplet microfluidics.

          Droplet-based microfluidic systems have been shown to be compatible with many chemical and biological reagents and capable of performing a variety of "digital fluidic" operations that can be rendered programmable and reconfigurable. This platform has dimensional scaling benefits that have enabled controlled and rapid mixing of fluids in the droplet reactors, resulting in decreased reaction times. This, coupled with the precise generation and repeatability of droplet operations, has made the droplet-based microfluidic system a potent high throughput platform for biomedical research and applications. In addition to being used as microreactors ranging from the nano- to femtoliter range; droplet-based systems have also been used to directly synthesize particles and encapsulate many biological entities for biomedicine and biotechnology applications. This review will focus on the various droplet operations, as well as the numerous applications of the system. Due to advantages unique to droplet-based systems, this technology has the potential to provide novel solutions to today's biomedical engineering challenges for advanced diagnostics and therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.

            Exosomes are 40-100nm extracellular vesicles that are released from a multitude of cell types, and perform diverse cellular functions including intercellular communication, antigen presentation, and transfer of oncogenic proteins as well as mRNA and miRNA. Exosomes have been purified from biological fluids and in vitro cell cultures using a variety of strategies and techniques. However, all preparations invariably contain varying proportions of other membranous vesicles that co-purify with exosomes such as shed microvesicles and apoptotic blebs. Using the colorectal cancer cell line LIM1863 as a cell model, in this study we performed a comprehensive evaluation of current methods used for exosome isolation including ultracentrifugation (UC-Exos), OptiPrep™ density-based separation (DG-Exos), and immunoaffinity capture using anti-EpCAM coated magnetic beads (IAC-Exos). Notably, all isolations contained 40-100nm vesicles, and were positive for exosome markers (Alix, TSG101, HSP70) based on electron microscopy and Western blotting. We employed a proteomic approach to profile the protein composition of exosomes, and label-free spectral counting to evaluate the effectiveness of each method. Based on the number of MS/MS spectra identified for exosome markers and proteins associated with their biogenesis, trafficking, and release, we found IAC-Exos to be the most effective method to isolate exosomes. For example, Alix, TSG101, CD9 and CD81 were significantly higher (at least 2-fold) in IAC-Exos, compared to UG-Exos and DG-Exos. Application of immunoaffinity capture has enabled the identification of proteins including the ESCRT-III component VPS32C/CHMP4C, and the SNARE synaptobrevin 2 (VAMP2) in exosomes for the first time. Additionally, several cancer-related proteins were identified in IAC-Exos including various ephrins (EFNB1, EFNB2) and Eph receptors (EPHA2-8, EPHB1-4), and components involved in Wnt (CTNNB1, TNIK) and Ras (CRK, GRB2) signalling. Copyright © 2012 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Controlling sound with acoustic metamaterials

                Bookmark

                Author and article information

                Contributors
                aozcelik@adu.edu.tr
                tony.huang@duke.edu
                Journal
                Microsyst Nanoeng
                Microsyst Nanoeng
                Microsystems & Nanoengineering
                Nature Publishing Group UK (London )
                2096-1030
                2055-7434
                3 June 2019
                3 June 2019
                2019
                : 5
                : 32
                Affiliations
                [1 ]ISNI 0000 0004 1936 7961, GRID grid.26009.3d, Department of Mechanical Engineering and Material Science, , Duke University, ; Durham, NC 27708 USA
                [2 ]ISNI 0000 0004 0595 4313, GRID grid.34517.34, Mechanical Engineering Department, , Aydin Adnan Menderes University, ; 09010 Aydin, Turkey
                [3 ]ISNI 000000041936754X, GRID grid.38142.3c, Department of Molecular and Cellular Biology, , Harvard University, ; Cambridge, MA 02138 USA
                Author information
                http://orcid.org/0000-0003-0086-5349
                http://orcid.org/0000-0002-3124-795X
                http://orcid.org/0000-0003-1205-3313
                Article
                64
                10.1038/s41378-019-0064-3
                6545324
                31231539
                f0874c33-8da0-400a-bff4-4536fda3e7f2
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 30 October 2018
                : 12 March 2019
                : 14 March 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100000002, U.S. Department of Health & Human Services | National Institutes of Health (NIH);
                Award ID: R01 HD086325, R44GM125439, and R43HL140800
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/100006751, United States Department of Defense | U.S. Army (United States Army);
                Award ID: W81XWH-18-1-0242
                Award Recipient :
                Categories
                Review Article
                Custom metadata
                © The Author(s) 2019

                engineering,chemistry,nanoscience and technology
                engineering, chemistry, nanoscience and technology

                Comments

                Comment on this article